NCT01837862 2024-07-05
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Northwell Health
Phase 1/2 Completed
Clinical Trials
7 trialsNCT02201381 2022-07-18
METRICS
Health Clinics Limited
Phase 3 Withdrawn
NCT02644291 2022-06-23
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT04443049 2021-10-05
To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.
Institute of Liver and Biliary Sciences, India
Phase NA Unknown
NCT01729260 2021-05-07
Mebendazole
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03628079 2020-01-22
RepoMeb
Repos Pharma
Phase 1/2 Terminated
NCT03925662 2019-04-24
Mebendazole as Adjuvant Treatment for Colon Cancer
Tanta University
Phase 3 Recruiting